Regulatory Updates
🌏 NMPA Page 4NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 37–48 of 87 articles
Onconic Therapeutics' Jakubo Enters Phase 3 Clinical Trials in China
Innovent Biologics and Pfizer: A $10.5B Oncology Partnership
PREMIA and Lind Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
Clinical Trials Market in Oncology: Size and Growth Insights for 2034
Global Drug Discovery Market to Exceed $174.92 Billion by 2035
Sun Pharma's USD11.75bn Acquisition of Organon: Market Analysis
Middle East Pharma Markets: Strategic Growth at API China 2026
AI Tools Transforming Clinical Trials in Life Sciences
Exosome-based Therapeutics Market Insights: 2033 Industry Report
Regulatory Strategy Reimagined: Trends Accelerating Drug Development
Medical Advances Soar With APAC's Clinical Trial Growth in Oncology
Immunotherapy Boom Fuels PET/CT Imaging Demand in Australia